NO854369L - Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivaterInfo
- Publication number
- NO854369L NO854369L NO854369A NO854369A NO854369L NO 854369 L NO854369 L NO 854369L NO 854369 A NO854369 A NO 854369A NO 854369 A NO854369 A NO 854369A NO 854369 L NO854369 L NO 854369L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- benzimidazole derivatives
- therapeutic active
- active benzimidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848427836A GB8427836D0 (en) | 1984-11-02 | 1984-11-02 | Chemical compounds |
| GB848432515A GB8432515D0 (en) | 1984-12-21 | 1984-12-21 | Heterocyclic compounds |
| GB858518043A GB8518043D0 (en) | 1985-07-17 | 1985-07-17 | Heterocyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO854369L true NO854369L (no) | 1986-05-05 |
| NO164541B NO164541B (no) | 1990-07-09 |
| NO164541C NO164541C (no) | 1990-10-17 |
Family
ID=27262502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO854369A NO164541C (no) | 1984-11-02 | 1985-11-01 | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0184322B1 (no) |
| KR (1) | KR930001410B1 (no) |
| CN (1) | CN1013445B (no) |
| AR (1) | AR241592A1 (no) |
| AU (1) | AU576634B2 (no) |
| CA (1) | CA1253150A (no) |
| DE (1) | DE3574873D1 (no) |
| DK (1) | DK501085A (no) |
| ES (1) | ES8701752A1 (no) |
| FI (1) | FI84718C (no) |
| GR (1) | GR852643B (no) |
| HU (1) | HU200763B (no) |
| IE (1) | IE58587B1 (no) |
| JO (1) | JO1406B1 (no) |
| NO (1) | NO164541C (no) |
| NZ (1) | NZ214024A (no) |
| PH (1) | PH22303A (no) |
| PT (1) | PT81420B (no) |
| ZW (1) | ZW19185A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0174717B1 (en) * | 1984-07-06 | 1992-01-22 | FISONS plc | Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors |
| GB2161160B (en) * | 1984-07-06 | 1989-05-24 | Fisons Plc | Heterocyclic sulphinyl compounds |
| GB8610607D0 (en) * | 1986-04-30 | 1986-06-04 | Smith Kline French Lab | Chemical compounds |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| DE3722810A1 (de) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung |
| US5668131A (en) * | 1993-12-01 | 1997-09-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Substituted aminoalkylaminopyridines |
| IL146504A0 (en) | 1999-06-07 | 2002-07-25 | Byk Gulden Lomberg Chem Fab | Pharmaceutical compositions containing an acid-labile active compound and processes for the preparation thereof |
| US7241890B2 (en) | 2001-10-30 | 2007-07-10 | Conforma Therapeutics Corporation | Purine analogs having HSP90-inhibiting activity |
| US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| EP1670802A4 (en) | 2003-09-18 | 2010-07-07 | Conforma Therapeutics Corp | NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF HSP90 PROTEIN |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| EP1869027A4 (en) * | 2005-03-30 | 2010-06-23 | Conforma Therapeutics Corp | ALKYNYL-PYRROLOPYRIMIDINES AND CORRESPONDING ANALOGS AS HSP90 INHIBITORS |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| CN101453993A (zh) | 2006-04-03 | 2009-06-10 | 伊萨·奥迪迪 | 含有机溶胶涂层的受控释放递送物件 |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL66340A (en) * | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
| US4575554A (en) * | 1983-12-05 | 1986-03-11 | The Upjohn Company | Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents |
| EP0174717B1 (en) * | 1984-07-06 | 1992-01-22 | FISONS plc | Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors |
| EP0178438A1 (en) * | 1984-09-19 | 1986-04-23 | Beecham Group Plc | Novel compounds |
| AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
| IL76837A0 (en) * | 1984-10-31 | 1986-02-28 | Byk Gulden Lomberg Chem Fab | Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing them |
| US4851419A (en) * | 1985-10-16 | 1989-07-25 | Fisons Plc | Certain 2-pyridinyl-phenylsulfinyl-benzoxazoles, the corresponding benzothiazoles or benzimidazoles having anti-inflammatory or gastric acid secretion inhibition activity |
| EP0806002A1 (en) * | 1995-11-24 | 1997-11-12 | Koninklijke Philips Electronics N.V. | A method for presenting virtual reality enhanced with tactile stimuli, and a system for executing the method |
-
1985
- 1985-10-24 JO JO19851406A patent/JO1406B1/en active
- 1985-10-28 CA CA000493978A patent/CA1253150A/en not_active Expired
- 1985-10-28 PH PH32987A patent/PH22303A/en unknown
- 1985-10-30 AU AU49207/85A patent/AU576634B2/en not_active Ceased
- 1985-10-30 AR AR85302116A patent/AR241592A1/es active
- 1985-10-30 ZW ZW191/85A patent/ZW19185A1/xx unknown
- 1985-10-30 FI FI854267A patent/FI84718C/fi not_active IP Right Cessation
- 1985-10-31 DK DK501085A patent/DK501085A/da not_active Application Discontinuation
- 1985-10-31 PT PT81420A patent/PT81420B/pt not_active IP Right Cessation
- 1985-10-31 DE DE8585307928T patent/DE3574873D1/de not_active Expired - Lifetime
- 1985-10-31 ES ES548409A patent/ES8701752A1/es not_active Expired
- 1985-10-31 EP EP85307928A patent/EP0184322B1/en not_active Expired
- 1985-10-31 NZ NZ214024A patent/NZ214024A/xx unknown
- 1985-11-01 HU HU854204A patent/HU200763B/hu not_active IP Right Cessation
- 1985-11-01 NO NO854369A patent/NO164541C/no unknown
- 1985-11-01 KR KR1019850008129A patent/KR930001410B1/ko not_active IP Right Cessation
- 1985-11-01 IE IE268485A patent/IE58587B1/en not_active IP Right Cessation
- 1985-11-02 CN CN85108133A patent/CN1013445B/zh not_active Expired
- 1985-11-04 GR GR852643A patent/GR852643B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI854267L (fi) | 1986-05-03 |
| NO164541B (no) | 1990-07-09 |
| KR930001410B1 (ko) | 1993-02-27 |
| ZW19185A1 (en) | 1986-05-21 |
| CN85108133A (zh) | 1986-04-10 |
| EP0184322B1 (en) | 1989-12-20 |
| EP0184322A1 (en) | 1986-06-11 |
| GR852643B (no) | 1986-03-05 |
| AU576634B2 (en) | 1988-09-01 |
| PH22303A (en) | 1988-07-22 |
| AR241592A1 (es) | 1992-09-30 |
| JO1406B1 (en) | 1986-11-30 |
| FI84718B (fi) | 1991-09-30 |
| CN1013445B (zh) | 1991-08-07 |
| PT81420A (en) | 1985-11-01 |
| NO164541C (no) | 1990-10-17 |
| ES8701752A1 (es) | 1986-12-01 |
| IE852684L (en) | 1986-05-02 |
| DK501085D0 (da) | 1985-10-31 |
| KR860004050A (ko) | 1986-06-16 |
| ES548409A0 (es) | 1986-12-01 |
| CA1253150A (en) | 1989-04-25 |
| DE3574873D1 (en) | 1990-01-25 |
| HUT39176A (en) | 1986-08-28 |
| IE58587B1 (en) | 1993-10-06 |
| FI854267A0 (fi) | 1985-10-30 |
| FI84718C (fi) | 1992-01-10 |
| HU200763B (en) | 1990-08-28 |
| DK501085A (da) | 1986-05-03 |
| PT81420B (pt) | 1988-05-27 |
| AU4920785A (en) | 1986-05-08 |
| NZ214024A (en) | 1989-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
| NO171638C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater | |
| NO851695L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater | |
| NO843979L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO167916C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater | |
| NO854369L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater | |
| NO843084L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater | |
| NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
| NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
| NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
| NO170976C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylbuten-syrederivater | |
| NO843042L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
| NO833527L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater | |
| NO820112L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater | |
| NO843377L (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater |